Executive Summary

Oct 2019
PROSPECTS
Free medication hits acetaminophen retail sales

In 2018 the public health system in Chile bought 230 million units of acetaminophen. The drug was distributed free of charge to patients in public hospitals and medical facilities.

Publicised side-effects of acetaminophen offers a boost for ibuprofen

A news segment broadcast on popular television network Chilevisión (CHV) noted the results of an American research piece titled “A social painkiller? Paracetamol reduces positive empathy”. The study, led by Ohio professor Dominik Mischkowski, explored the unwanted side effects of acetaminophen - such as temporarily reduced empathy and pleasure.

Public health fund to slash the price of medication

In 2019 The National Health Fund (Fonasa) announced a plan to reduce the prices of more than 2,000 medications, allowing customers to purchase them from OTC suppliers at lowered prices. Most of the products with prices reduced by chemists/pharmacies were analgesics, antiallergics and vitamins.

COMPETITIVE LANDSCAPE
Actron Plus goes head-to-head against private label

In 2019 competition was tough for private label. Laboratories and brands directly hit private label by highlighting the benefits of buying branded medication.

Illegal market of analgesics a threat to sales

In 2019 a 23-year-old man was arrested for selling 80 boxes of medication at a fair in Nonguén, Chile. Both Rx and OTC medication were hit by the illegal sales, with authorities warning the public not to purchase these drugs - they did not comply with regulations, had inadequate storage conditions and were from unknown sources.

GSK and Pfizer merger sees Anadin exit

As a result of the merger between GSK and Pfizer, Anadin will exit analgesics in 2020. GSK and Pfizer announced in late-2018 that their joint venture will create a premier global consumer healthcare company.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Chile

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Chile with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Chile, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Chile market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Chile?
  • What are the major brands in Chile?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Chile - Category analysis

HEADLINES

PROSPECTS

Free medication hits acetaminophen retail sales
Publicised side-effects of acetaminophen offers a boost for ibuprofen
Public health fund to slash the price of medication

COMPETITIVE LANDSCAPE

Actron Plus goes head-to-head against private label
Illegal market of analgesics a threat to sales
GSK and Pfizer merger sees Anadin exit

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Chile - Industry Overview

EXECUTIVE SUMMARY

Consumer health remains healthy as contagious diseases spread
Chileans reaching for natural solutions above OTC
Competition gets tough for OTC as Chileans look for health options
Online chemists/pharmacies get serious as consumer health data is stored in the cloud
Consumer health products with natural offerings are set to see positive results

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2018-2019

DEFINITIONS

SOURCES

Summary 2 Research Sources